Endothelin-1 across conditions

Endothelin-1 appears in 2 entries of the OSMF biomarker atlas, covering Hypertension, Long COVID. Across those entries it is elevated in 2. Because the same marker shifts in several unrelated conditions, it is best understood as a signal of shared biology such as inflammation, vascular or metabolic stress rather than as a condition-specific test. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

HypertensionLong COVID

Where Endothelin-1 is reported

Also listed as: Vasoactive peptide

ConditionDirectionCompared againstAssociated symptomsSource
Hypertension↑ elevatedpatients with moderate to severe hypertension vs. normotensive individualsmoderate to severe hypertensionIglarz et al. 2003
Long COVID↑ elevatedhealthy controlsVasoconstriction, POTSThomas et al. 2024

Frequently asked questions

In which conditions is Endothelin-1 altered?

In the OSMF atlas Endothelin-1 is reported in Hypertension, Long COVID. It is elevated in 2 across 2 entries.

Does Endothelin-1 point to one specific diagnosis?

No. Because Endothelin-1 changes in several conditions (Hypertension, Long COVID), an abnormal result cannot identify which condition, if any, is present. It must be interpreted with symptoms, history and other tests.

What is the LOINC code for Endothelin-1?

Entries in this atlas use LOINC 49867-5. LOINC codes identify the laboratory observation so results can be compared across systems.

Is one abnormal Endothelin-1 result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). Endothelin-1 across conditions: biomarker evidence. OSMF Research Tracker. Retrieved November 21, 2026, from https://research.opensourcemed.info/biomarkers/markers/endothelin-1.html

Last reviewed: 2026-10-08 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.